Immuron Limited (ASX:IMC) Filings

Immuron Limited

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerNov 18, 2026Current reportSEC
Results of Annual General MeetingNov 18, 2026Meeting outcomeASX
CEO AddressNov 17, 2026Annual reportASX
6-K · Report of a foreign issuerNov 10, 2026Current reportSEC
Immuron Engages LifeSci CapitalNov 10, 2026Other filingsASX
6-K · Report of a foreign issuerOct 28, 2026Current reportSEC
Emerging Growth Conference PresentationOct 28, 2026Other filingsASX
6-K · Report of a foreign issuerOct 27, 2026Current reportSEC
Immuron Updates At-The-Market Funding FacilityOct 26, 2026FinancingASX
Immuron FY27 Sales UpdateOct 26, 2026ResultsASX
6-K · Report of a foreign issuerOct 23, 2026Current reportSEC
424B5 · ProspectusOct 23, 2026Offer documentSEC
6-K · Report of a foreign issuerOct 21, 2026Current reportSEC
CEO to present at Emerging Growth ConferenceOct 21, 2026Notification letterASX
6-K · Report of a foreign issuerOct 16, 2026Current reportSEC
Notice of Annual General Meeting and Proxy FormOct 15, 2026Meeting noticeASX
6-K · Report of a foreign issuerOct 13, 2026Current reportSEC
Travelan Phase 2 Study Results PublishedOct 12, 2026ResultsASX
Change in substantial holdingSep 30, 2026Ownership change noticeASX
20-F · Annual reportSep 24, 2026Annual reportSEC
6-K · Report of a foreign issuerSep 24, 2026Current reportSEC
Appendix 4G and Corporate Governance StatementSep 24, 2026Other filingsASX
Annual ReportSep 24, 2026Annual reportASX
6-K · Report of a foreign issuerSep 21, 2026Current reportSEC
Presentation to Coffee Microcaps ConferenceSep 21, 2026Other filingsASX
6-K · Report of a foreign issuerSep 3, 2026Current reportSEC
PROIBS US Distribution AgreementSep 3, 2026Operations updateASX
6-K · Report of a foreign issuerAug 28, 2026Current reportSEC
FY26 Results PresentationAug 27, 2026Other filingsASX
Appendix 4E Preliminary Final ReportAug 27, 2026ResultsASX
6-K · Report of a foreign issuerAug 18, 2026Current reportSEC
Emerging Growth Conference PresentationAug 18, 2026Other filingsASX
6-K · Report of a foreign issuerAug 12, 2026Current reportSEC
Emerging Growth ConferenceAug 12, 2026Meeting noticeASX
6-K · Report of a foreign issuerJul 27, 2026Current reportSEC
6-K · Report of a foreign issuerJul 20, 2026Current reportSEC
6-K · Report of a foreign issuerJul 20, 2026Current reportSEC
6-K · Report of a foreign issuerJul 15, 2026Current reportSEC
Immuron FY26 Sales UpdateJul 15, 2026ResultsASX
6-K · Report of a foreign issuerJul 6, 2026Current reportSEC
6-K · Report of a foreign issuerJun 29, 2026Current reportSEC
6-K · Report of a foreign issuerJun 22, 2026Current reportSEC
6-K · Report of a foreign issuerJun 18, 2026Current reportSEC
6-K · Report of a foreign issuerMay 28, 2026Current reportSEC
3 · Initial statement of ownershipMay 14, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 14, 2026Insider tradeSEC
6-K · Report of a foreign issuerMay 7, 2026Current reportSEC
3 · Initial statement of ownershipMay 4, 2026Insider tradeSEC
6-K · Report of a foreign issuerApr 30, 2026Current reportSEC
3 · Initial statement of ownershipApr 29, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 29, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 29, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 29, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 29, 2026Insider tradeSEC
6-K · Report of a foreign issuerApr 16, 2026Current reportSEC
6-K · Report of a foreign issuerApr 13, 2026Current reportSEC
6-K · Report of a foreign issuerMar 5, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 27, 2026Current reportSEC
Strategic Update and HY26 ResultsFeb 25, 2026Other filingsASX
Appendix 4D and Half Year ReportFeb 25, 2026Interim reportASX
6-K · Report of a foreign issuerFeb 17, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 12, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 9, 2026Current reportSEC
6-K · Report of a foreign issuerJan 22, 2026Current reportSEC
6-K · Report of a foreign issuerJan 20, 2026Current reportSEC
6-K · Report of a foreign issuerJan 14, 2026Current reportSEC
6-K · Report of a foreign issuerJan 12, 2026Current reportSEC
6-K · Report of a foreign issuerDec 16, 2025Current reportSEC
6-K · Report of a foreign issuerDec 15, 2025Current reportSEC
6-K · Report of a foreign issuerDec 12, 2025Current reportSEC
Uniformed Services University to Release Topline DataDec 9, 2025Operations updateASX
6-K · Report of a foreign issuerDec 9, 2025Current reportSEC
6-K · Report of a foreign issuerDec 5, 2025Current reportSEC
6-K · Report of a foreign issuerDec 4, 2025Current reportSEC
6-K · Report of a foreign issuerDec 3, 2025Current reportSEC
6-K · Report of a foreign issuerDec 3, 2025Current reportSEC
6-K · Report of a foreign issuerNov 21, 2025Current reportSEC
6-K · Report of a foreign issuerNov 12, 2025Current reportSEC
6-K · Report of a foreign issuerNov 6, 2025Current reportSEC
6-K · Report of a foreign issuerNov 6, 2025Current reportSEC
6-K · Report of a foreign issuerNov 5, 2025Current reportSEC
IMM-529 IND approved by FDANov 5, 2025Other filingsASX
Clinical Trial UpdateOct 30, 2025Operations updateASX
6-K · Report of a foreign issuerOct 30, 2025Current reportSEC
6-K · Report of a foreign issuerOct 27, 2025Current reportSEC
Immuron launch PROIBS for IBSOct 23, 2025Operations updateASX
6-K · Report of a foreign issuerOct 23, 2025Current reportSEC
6-K · Report of a foreign issuerOct 22, 2025Current reportSEC
6-K · Report of a foreign issuerOct 20, 2025Current reportSEC
6-K · Report of a foreign issuerOct 20, 2025Current reportSEC
6-K · Report of a foreign issuerOct 20, 2025Current reportSEC
6-K · Report of a foreign issuerOct 17, 2025Current reportSEC
6-K · Report of a foreign issuerOct 14, 2025Current reportSEC
6-K · Report of a foreign issuerOct 10, 2025Current reportSEC
6-K · Report of a foreign issuerOct 7, 2025Current reportSEC
424B5 · ProspectusOct 3, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 3, 2025Current reportSEC
6-K · Report of a foreign issuerOct 1, 2025Current reportSEC
6-K · Report of a foreign issuerSep 30, 2025Current reportSEC
6-K · Report of a foreign issuerSep 25, 2025Current reportSEC
20-F · Annual reportSep 25, 2025Annual reportSEC
6-K · Report of a foreign issuerSep 16, 2025Current reportSEC
6-K · Report of a foreign issuerSep 2, 2025Current reportSEC
FY25 Results PresentationAug 28, 2025Other filingsASX
Appendix 4E Preliminary Final ReportAug 28, 2025ResultsASX
6-K · Report of a foreign issuerAug 26, 2025Current reportSEC
6-K · Report of a foreign issuerAug 15, 2025Current reportSEC
6-K · Report of a foreign issuerAug 13, 2025Current reportSEC
6-K · Report of a foreign issuerJul 21, 2025Current reportSEC
6-K · Report of a foreign issuerJul 18, 2025Current reportSEC
6-K · Report of a foreign issuerJul 17, 2025Current reportSEC
6-K · Report of a foreign issuerJul 17, 2025Current reportSEC
FY25 global sales exceed projection, up 49% on prior yearJul 16, 2025ResultsASX
6-K · Report of a foreign issuerJun 4, 2025Current reportSEC
6-K · Report of a foreign issuerMay 30, 2025Current reportSEC
6-K · Report of a foreign issuerApr 11, 2025Current reportSEC
6-K · Report of a foreign issuerApr 10, 2025Current reportSEC
Immuron Travelan highest sales in historyApr 10, 2025ResultsASX
6-K · Report of a foreign issuerMar 7, 2025Current reportSEC
6-K · Report of a foreign issuerMar 5, 2025Current reportSEC
IMC and Calmino to treat Irritable Bowel Syndrome (IBS)Mar 4, 2025Other filingsASX
6-K · Report of a foreign issuerFeb 28, 2025Current reportSEC
6-K · Report of a foreign issuerFeb 18, 2025Current reportSEC
6-K · Report of a foreign issuerJan 17, 2025Current reportSEC
Immuron Travelan continued strong sales growthJan 16, 2025ResultsASX
6-K · Report of a foreign issuerJan 15, 2025Current reportSEC
6-K · Report of a foreign issuerJan 14, 2025Current reportSEC
Immuron Announces Travelan Clinical Trial UpdateJan 14, 2025Operations updateASX
6-K · Report of a foreign issuerJan 10, 2025Current reportSEC
6-K · Report of a foreign issuerJan 8, 2025Current reportSEC
6-K · Report of a foreign issuerDec 10, 2024Current reportSEC
6-K · Report of a foreign issuerNov 22, 2024Current reportSEC
6-K · Report of a foreign issuerNov 18, 2024Current reportSEC
6-K · Report of a foreign issuerNov 14, 2024Current reportSEC
6-K · Report of a foreign issuerOct 29, 2024Current reportSEC
6-K · Report of a foreign issuerOct 18, 2024Current reportSEC
6-K · Report of a foreign issuerOct 16, 2024Current reportSEC
6-K · Report of a foreign issuerOct 15, 2024Current reportSEC
6-K · Report of a foreign issuerOct 8, 2024Current reportSEC
NMRC Reports Results for Campylobacter Clinical StudyOct 4, 2024ResultsASX
6-K · Report of a foreign issuerOct 4, 2024Current reportSEC
Trading HaltOct 2, 2024Trading halt or suspensionASX
20-F · Annual reportOct 1, 2024Annual reportSEC
6-K · Report of a foreign issuerSep 26, 2024Current reportSEC
6-K · Report of a foreign issuerSep 9, 2024Current reportSEC
6-K · Report of a foreign issuerSep 5, 2024Current reportSEC
Immuron Plans Phase 2 Trial for IMM-529 following FDA reviewSep 5, 2024Other filingsASX
Appendix 4E and Preliminary Final ReportAug 30, 2024ResultsASX
6-K · Report of a foreign issuerAug 21, 2024Current reportSEC
6-K · Report of a foreign issuerAug 16, 2024Current reportSEC
6-K · Report of a foreign issuerAug 8, 2024Current reportSEC
6-K · Report of a foreign issuerAug 7, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveJul 22, 2024Other filingsSEC
6-K · Report of a foreign issuerJul 18, 2024Current reportSEC
CORRESP · Letter to the SECJul 18, 2024Other filingsSEC
6-K · Report of a foreign issuerJul 15, 2024Current reportSEC
Immuron Travelan record sales globally, Australia and USAJul 14, 2024ResultsASX
6-K · Report of a foreign issuerJul 9, 2024Current reportSEC
UPLOAD · Letter from the SECJul 8, 2024Other filingsSEC
6-K · Report of a foreign issuerJul 5, 2024Current reportSEC
6-K · Report of a foreign issuerJul 3, 2024Current reportSEC
F-3 · Registration statementJul 2, 2024Offer documentSEC
6-K · Report of a foreign issuerJul 2, 2024Current reportSEC
IMM-529 pre-IND FDA filingJul 1, 2024Other filingsASX
6-K · Report of a foreign issuerJun 5, 2024Current reportSEC
6-K · Report of a foreign issuerMay 31, 2024Current reportSEC
6-K/A · Report of a foreign issuer, amendedMay 24, 2024Current reportSEC
6-K · Report of a foreign issuerMay 3, 2024Current reportSEC
6-K · Report of a foreign issuerApr 23, 2024Current reportSEC
6-K · Report of a foreign issuerApr 15, 2024Current reportSEC
6-K · Report of a foreign issuerApr 10, 2024Current reportSEC
Immuron Travelan sales continued strong growthApr 9, 2024ResultsASX
6-K · Report of a foreign issuerMar 14, 2024Current reportSEC
6-K · Report of a foreign issuerMar 7, 2024Current reportSEC
Travelan to progress to Phase 3 Clinical Trials in the USMar 6, 2024Operations updateASX
6-K · Report of a foreign issuerMar 4, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 28, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 21, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 13, 2024Current reportSEC
Immuron achieves record Travelan salesFeb 12, 2024ResultsASX
6-K · Report of a foreign issuerFeb 8, 2024Current reportSEC
6-K · Report of a foreign issuerJan 16, 2024Current reportSEC
Immuron achieves record half yearly Travelan salesJan 15, 2024ResultsASX
6-K · Report of a foreign issuerDec 22, 2023Current reportSEC
6-K · Report of a foreign issuerDec 4, 2023Current reportSEC
First Patients Enrolled in Campylobacter Clinical StudyDec 4, 2023Operations updateASX
6-K · Report of a foreign issuerNov 28, 2023Current reportSEC
6-K · Report of a foreign issuerNov 22, 2023Current reportSEC
6-K · Report of a foreign issuerNov 21, 2023Current reportSEC
6-K · Report of a foreign issuerNov 13, 2023Current reportSEC
6-K · Report of a foreign issuerOct 30, 2023Current reportSEC
6-K · Report of a foreign issuerOct 23, 2023Current reportSEC
6-K · Report of a foreign issuerOct 18, 2023Current reportSEC
6-K · Report of a foreign issuerOct 11, 2023Current reportSEC
Immuron achieves record quarterly Travelan salesOct 11, 2023ResultsASX
6-K · Report of a foreign issuerOct 3, 2023Current reportSEC
6-K · Report of a foreign issuerSep 28, 2023Current reportSEC
20-F · Annual reportSep 28, 2023Annual reportSEC
6-K · Report of a foreign issuerSep 13, 2023Current reportSEC
Immuron achieves record monthly Travelan salesSep 13, 2023ResultsASX

This page holds 200 of 604 filings.

All of its filings on SEC EDGAR